FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Nashville Airport Authority Votes Unanimously to Change Name to Honor Dolly Parton

Watch: Convention Crowd Symbolically Anoints JD Vance for 2028 with Chant

Inside Trump’s intimate meeting with nation’s bravest soldiers during whirlwind Texas trip

California woman chased, fatally shot by illegal immigrant DoorDash driver who stalked her for months: DHS

AOC, Mamdani interaction caught on cam at 9/11 memorial sparks online fury

Breaking: Newly Declassified 9/11 Documents Reveal the Repeated Warnings Received by Clinton and Bush

The ‘Jumper’ Victims of 9/11 Deserve to Have Their Stories Heard: And Yet They’ve Been Erased by the Media

Attacks of 9/11 sent Rep. Eli Crane into the military and shaped the way he views the Iran war

Texas man remembered by Fox News hosts after repeat offender arrested in savage park bench slaying

Reporter’s Notebook: Countdown is on as Senate races to pass crypto, college sports bills

Court documents show groups inspiring ‘satanist’ teenager’s alleged plans to attack Christians

AOC’s ‘modern-day lynchings’ claim torn to shreds online as Black hanging case findings tell a different story

Mamdani greets America’s Mayor Rudy Giuliani despite calls to skip 9/11 memorial

Flashback: How James Woods Encountered, Then Reported Multiple 9/11 Hijackers to the FBI

Trump Rejects Saudi Crown Prince’s Pleas for New U.S. Strikes in Middle East: Report

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”